$GBX

Greenbrier Companies Q3 Profit Falls

Greenbrier Companies (GBX) reported Q3 GAAP profit of $18.9M, or $0.60/share, down from $60.1M, or $1.86/share, a year earlier. Revenue fell 31.6% to $576.5M from $842.7M. The company guided full-year EPS to $3.00–$3.15 and revenue to $2.4B–$2.5B.

Original reporting
Published Jul 1, 2026, 11:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 11:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Greenbrier Companies Q3 Profit Falls — source image
Decision brief

The 30-second read

$GBXBearishMed
01

Why it matters

Traders can use the disclosed EPS/revenue declines and the stated full-year guidance to update near-term models and positioning for the next earnings cycle.

02

Market read

Fresh earnings and guidance datapoints provide a concrete basis for estimate revisions and near-term sentiment around the industrial/railcar cycle.

03

What to watch

The article lacks segment detail, margin drivers, backlog, and any one-time items; those could materially change how traders interpret the guidance.

Relevance 8/10Novelty 7/10Timing: after-hours earnings/guidance update (published 2026-07-01 23:30 UTC)

Background

The piece is a straightforward earnings release summary for Greenbrier Companies’ third quarter, including GAAP results and full-year guidance ranges.

Company-level read

Ticker impact

$GBXBearishMedium confidence
Context

Greenbrier Companies reported Q3 GAAP EPS of $0.60 and revenue of $576.5M, both down sharply year over year, plus full-year guidance ranges.

Expected impact

Bias toward downside/volatility until investors assess whether guidance offsets the steep Q3 contraction.

Evidence & confidence

The article discloses the core earnings datapoints (EPS, revenue) and guidance ranges; without consensus/Street context, magnitude of reaction is uncertain but directionally negative.

Market effects

Signals demand/earnings pressure in railcar/industrial equipment end-markets, which can affect sentiment across similar cyclicals.

Limited direct regional read-through; impact mainly via industrial/transportation supply-chain sentiment.

Primarily US-listed company earnings; broader global impact likely modest unless guidance implies wider cycle deterioration.

Counterpoint

If the guidance ranges are viewed as resilient relative to the Q3 drop, the selloff could be overdone and support a rebound trade.

Key entities

  • Greenbrier Companies

    Reported Q3 GAAP EPS of $0.60 vs. $1.86 prior year and revenue of $576.5M vs. $842.7M, with full-year EPS guidance $3.00–$3.15 and revenue guidance $2.4B–$2.5B.

Related articles

$GBXMed

Rail supplier news from Greenbrier, Hitachi Rail and CPaT. For Railroad Career Professionals

Greenbrier reported Q3 FY2026 net earnings of $19M (60 cents/diluted share) on revenue of $576.5M, versus Q3 FY2025 net earnings of $60M (1.86/diluted share) on revenue of $843M. It booked 2,200 railcar orders worth $340M and delivered 3,600 units, lifting backlog to 13,800 units (~$2B). Hitachi Rail said it completed its acquisition of Clever Devices, projecting 2026 revenue over $220M.

$GBXMed

GREENBRIER COMPANIES INC (GBX): Results of Operations and Financial Condition

GREENBRIER COMPANIES INC (GBX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 gbx-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Earnings Release One Centerpointe Drive, Suite 200, Lake Oswego, Oregon 97035 503-684-7000 www.gbrx.com July 1, 2026 Contact: Travis Williams, Investor Relations Jack Isselmann, Media Relations Ph: 503-684-7000 Greenbrier Repo

$GBXMedAI 8/10

On deadline for approval, The Greenbrier's casino license is in purgatory

The West Virginia Lottery Commission said The Greenbrier’s limited gaming license renewal is stalled because required audited financial statements were not submitted on time. Acting Director David Bradley said the commission cannot renew without the audit, and commissioners voted not to renew as of Friday, though the license remains valid through June 30. The commission may reconsider after review.

$FSMMed

Fortuna Mining Q2 Earnings Call Highlights

Fortuna Mining (NYSE:FSM) reported Q2 gold output of 41,683 oz at Séguéla with cash costs of $676/oz and AISC of $1,765/oz. The board approved a $109M Séguéla process-plant expansion plus a $48M underground budget. Management cited Diamba Sud feasibility for 158,000 oz/yr and a potential 2026 final investment decision. Liquidity was ~$756M and it repurchased $82M of shares.

$FTKMedAI 8/10

Flotek Industries Q2 Earnings Call Highlights

Flotek Industries (NYSE:FTK) reported Q2 highlights including chemistry revenue up 53% year over year to $31 million in June, with international chemistry revenue up 172%. Management said contracted backlog exceeded $500 million and utility, infrastructure and data-center pipeline could top $1 billion. It raised FY guidance to revenue $340M-$350M and adjusted EBITDA $47M-$51M. A 10-year Puerto Rico PREPA deal adds about $400M backlog through 2036.

$DRIMedAI 8/10

DRI Healthcare Reports Second Quarter 2026 Results and New Board Appointment

DRI Healthcare Trust (TSX: DHT.UN, DHT.U) reported Q2 2026 results for the quarter ended June 30, 2026: total income $50.1M, total cash receipts $46.5M, and adjusted EBITDA $42.6M. It repurchased 89,513 units at $11.65 and paid a $0.11/unit distribution. After quarter-end, it exercised a put option on Ekterly for about $178M and received FDA approval for Lumvoa (veligrotug), triggering $75M milestone payments.